Secreted frizzled-related proteins (sFRPs) comprise a family of five secreted glycoproteins that antagonize Wnt signaling. Aberrant activation and upregulation of the Wnt pathway is a key feature of many cancers. Thus, role of sFRP as a negative regulator of Wnt signaling may have important implications in tumorigenesis, and its downregulation has been correlated with human cancers. Recently, we reported Wnt signaling and dishevelled (Dvl) overexpression in malignant pleural mesothelioma (MM). Here, we report significant transcriptional downregulation of the SFRP gene family in MM primary tissues and cell lines as well as several other cancer cell lines (breast, lung, glioma, and cervical) compared to normal cells. One or more SFRPs were downregulated in approximately 85% (18 of 21) of primary MM tumor specimens compared to normal pleural tissue. Eight of the nine cancer cell lines we examined showed silencing of the SFRP family. Methylation-specific PCR (MSP) analysis showed that SFRP1, SFRP4, and SFRP5 gene promoters are frequently methylated in MM primary tissue (480%). Furthermore, transfection of the SFRP gene construct into MM cell lines lacking SFRP expression resulted in apoptosis and growth suppression. Our results suggest that methylation silencing of SFRPs may be one of the important mechanisms of aberrant Wnt signaling activation in MM. Oncogene (2004 Oncogene ( ) 23, 6672-6676. doi:10.1038 
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Keywords: SFRP; Wnt signaling; methylation; malignant pleural mesothelioma Malignant pleural mesothelioma (MM) is a highly aggressive tumor with a very poor prognosis. In the US, approximately 3000 patients are diagnosed each year, and the number of incidents is expected to steadily rise and peak over the next two decades (Butchart, 1999; Lee et al., 2000) . Unfortunately, the disease is largely unresponsive to conventional chemotherapy or radiotherapy, and most patients die within 12-15 months of the first symptoms (Butchart, 1999) . The molecular basis of the development of mesothelioma is largely unknown.
Wnt glycoproteins comprise a family of extracellular signaling ligands that play essential roles in cell proliferation, patterning, and fate determination during normal developmental processes. Although this signaling is critical for normal embryonic development, the aberrant activation of the Wnt signal transduction pathway has been closely linked to tumorigenesis in adults (Giles et al., 2003; Lustig and Behrens, 2003) . In the resting state of the Wnt pathway, b-catenin is phosphorylated by glycogen synthase kinase b (GSK3b) in a mutiprotein complex with casein kinase 1 (CK1), adenomatous polyposis coli (APC), and Axin. Immediately following b-catenin phosphorylation is its rapid degradation via the ubiquitin proteosome pathway. Upon the binding of the Wnt ligand to the frizzled membrane receptor, the Wnt signal transduction pathway is activated. This results in the inactivation of GSK3b and thus an increase in the cytoplasmic pool of b-catenin. Subsequently, this stable form of b-catenin becomes translocated to the cell nucleus where it interacts with members of the T-cell factor/lymphocyte enhancer factor (TCF/LEF) family of transcription factors to promote expression of Wnt-responsive genes (Giles et al., 2003; Lustig and Behrens, 2003) . These downstream gene targets include developmental regulators and other genes involved in cell proliferation and cancer progression, including c-myc, c-jun, and cyclin D (Jones and Jomary, 2002) .
Recently, frizzled-related proteins (sFRPs), a family of five secreted glycoproteins, have been identified as possible modulators of the Wnt signal transduction pathway. The sFRPs share a similar sequence with the frizzled receptor extracellular domain (Finch et al., 1997; Rattner et al., 1997; Hu et al., 1998) . The CRD of frizzled receptors have been shown to serve as the putative binding site of the Wnt ligand. Cell surface binding and in vitro interactions assays indicate that sFRPs are also capable of directly interacting with and binding to the Wnt molecules (Bafico et al., 1999; Uren et al., 2000) . In contrast to the frizzled family proteins, however, sFRPs lack any transmembrane region or cytoplasmic domain required to transduce Wnt signaling within the cell (Finch et al., 1997) . Thus, sFRPs, based on their ability to bind and sequester the Wnt ligands, provide an important method for modulating Wnt signaling (Hu et al., 1998; Wang et al., 1997) . Studies using the Xenopus developmental model have shown that sFRP inhibits Wnt-dependent morphological alterations such as axial duplication, suggesting that sFRP may behave like a dominant-negative receptor to the Wnt signaling pathway (Finch et al., 1997) . In addition, Bafico et al. demonstrated that sFRP antagonizes the Wnt-induced increase in uncomplexed bcatenin in both transient cotransfection and stable transformation models, where, again, Wnt-induced morphologic alterations are inhibited as well.
Although Wnt signaling's involvement in carcinogenesis has been studied quite extensively, the associations of the sFRP family to tumorigenesis have only recently begun to be explored. Previous studies have shown sFRP downregulation in colorectal cancer, gastric cancer (Suzuki et al., 2002) , and invasive breast tumors (Zhou et al., 1998; Wong et al., 2002) . To date, there has been no data on sFRP in human tumors of mesenchymal origin, including MM. In this study, we performed semiquantitative RT-PCR analysis on MM primary tissue specimens as well as various cell lines.
To confirm and extend previous findings with respect to SFRP, the mRNA levels of four members of the SFRP family-SFRP1, SFRP3, SFRP4, and SFRP5-were examined. The analysis of mRNA levels in cell lines ( Figure 1a ) shows a clear disparity in expression levels of normal and tumor samples, with a significantly lower level of SFRP expression associated with the neoplastic state. In the majority of cases, there was a complete absence of expression in cancer cell lines. The two MM lines (MS-1 and H28), three of the four lung cancer cell lines (H460, H838, and H1703), one glioblastoma line (U87), one breast cancer line (MCF7), and one cervical cancer cell line (HeLa) have no detectable levels of expression in this assay. In contrast, the two normal cell lines display notable expression of two or more of the SFRPs. A549, a lung cancer line, appears to express SFRP1 and SFRP4 though at a much lower level than the SFRPs expressed in the normal cells. Similarly, our analysis of mRNA levels in the primary mesothelioma tissue (Figure 1b ) demonstrates notable differences between normal and tumor specimens. We show that the five normal pleural tissue specimens examined expressed considerable levels of all four SFRPs. In contrast, none of the MM samples expressed all four SFRPs. SFRP1 expression was silenced or significantly reduced in 10 of 21 (48%) primary MM tissue specimens relative to the normal pleural tissue. SFRP3, SFRP4, and SFRP5 were markedly downregulated or silenced in 80% (17 of 21), 52% (11 of 21), and 76% (16 of 21) of the tumor specimens, respectively. Surprisingly, in a few of cases, such as SFRP1 in sample 8, there appears to be a considerable overexpression of an SFRP gene compared to the normal controls. In the majority of cases, however, SFRP appears to be downregulated in the MM samples compared to normal pleural tissue samples. Particularly notable are MM tissue samples 12, 13, 14, 15, 16, 20, and 21 , which appear to lack expression of any of the SFRP genes. Together, this data indicates that SFRP mRNA is highly expressed in normal cell lines and normal tissue, and underexpression appears to be correlated with the neoplastic state. There are a few notable exceptions to this pattern, as described above, suggesting a greater complexity behind the role of sFRP in mesothelioma. Interestingly, macrophages have also been found to express sFRP family members (Ijiri et al., 2002) , suggesting that inflammatory reactions might also play a role in sFRP expression detected in tissue samples.
To date, no mutation in SFRP genes have been associated with their dysregulation in tumors (Jones and Jomary, 2002) . Aberrant hypermethylation of CpG islands in gene promoters has been found to be a primary mechanism in the inactivation of several tumor suppressor genes (Baylin 2002) . A recent genomic screen Fresh MM tissue from patients were collected at the time of surgery, and immediately snap-frozen in liquid nitrogen. Total RNA was isolated from cell cultures and surgical specimens by homogenization in Trizol reagents according to the manufacturer's instructions (Invitrogen Life Technologies, Inc.). A 395-bp fragment of a gene encoding the 60S large subunit ribosomal protein L19 was used as an internal control to ensure RNA quality and loading accuracy. Reactions were performed in GeneAmp PCR system 9700 using One-step RT-PCR Kit from Life Technologies Inc., according to the manufacture's protocol sFRP silencing in human mesothelioma AY Lee et al for genes upregulated by demethylation in human colorectal cancer identified the frequent hypermethylation of four genes in the SFRP family (Suzuki et al., 2002) . To determine the reason behind the dysregulation in SFRP expression levels associated with MM, we examined the methylation status of SFRP promoters in MM samples.
We assessed the methylation status of the CpG islands in the SFRP1 gene promoter in MM primary tissue (Figure 2) . For this purpose, we performed genomic DNA bisulfite treatment followed by methylationspecific PCR (MSP). Primer sequences were kindly provided by Dr Suzuki at Johns Hopkins. We found methylation of SFRP1 in all (19 of 19) of the tumor specimens we examined (Figure 2b ). In contrast, SFRP1 appears to be predominantly unmethylated in the two normal controls -a normal lung fibroblast cell line and a normal small airway epithelial cell primary culture (Figure 2a) . We also performed MSP analysis on primary mesothelioma specimens for additional members of the SFRP family -SFRP4 and SFRP5 (Figure 3 ). SFRP3 was not analyzed for methylation as this gene was previously found not to contain a CpG island (Suzuki et al., 2002) . The majority of the tumor specimens had methylation of SFRP4 and SFRP5. We found methylation of SFRP4 in 89% (17 of 19) of cases and methylation of SFRP5 in 79% (15 of 19) of cases.
Five tumor tissue samples in the RT-PCR and methylation analyses were derived from the same patients: cases 1, 2, 6, 13, and 21. With the exception of SFRP4 in cases 6 and 21, there appears to be a strong correlation between the methylation status of the SFRP gene promoter and its transcriptional downregulation in these tissue samples.
It is important to note that primary tissue specimens were not microdissected. Rather, tumors were excised from the patient according to the margins of the tumor. As such, there lies the possibility that the tumor sample may be contaminated with a small population of normal cells and vice versa, posing a challenge to precise quantification of methylation in normal and tumor cells.
Additionally, we investigated whether restoration of SFRP would result in growth suppression and apoptosis in mesothelioma cell lines in which SFRP is silenced. Analysis by flow cytometry showed a significantly higher level of apoptosis induction in SFRP4-transfected H290 cells than in empty vector-transfected or untransfected H290 cells (approximately 44.5, 4.8, and 3.4% at 1 week after transfection, respectively) ( Figure 4a ). Expression of SFRP4 in SFRP4-transfected cells was confirmed by RT-PCR (Figure 4b ). The inhibition of Wnt signaling was confirmed by checking the levels of cytosolic b-catenin. At 1 week after transfection, cytosolic b-catenin was undetectable by Western blot in SFRP4-transfected H290 cells (Figure 4b ). In contrast, both nontransfected and empty vector-transfected H290 cells had relatively high levels of b-catenin in the cytoplasm. Furthermore, an inhibitor of apoptosis, Survivin, was also significantly downregulated in SFRP4-transfected H290 cells (Figure 4b ). After selection of drug-resistant colonies for 3 weeks, we found that the colony numbers of SFRP4 transfected cells significantly decreased compared with that of empty vector-transfected cells (Po0.001 for MS1 and Po0.01 for H290) (Figure 4c ).
Increasing evidence indicates that aberrations in the Wnt signal transduction pathway may contribute to Figure 2 Methylation status of SFRP1 in malignant pleural MM primary tissue. Bisulfite-treated genomic DNA was amplified using either a methylation-specific or unmethylation-specific primer set. (a) MSP analysis of matched pairs of mesothelioma (T) and normal pleural (N) primary tissue. Bands in lanes labeled 'U' are unmethylated DNA product amplified with unmethylation-specific primers. Bands in lanes labeled 'M' are methylated DNA product amplified with MSPs. CCL-75 is a normal lung fibroblast cell line and SAEC is a normal human small airway epithelial cell primary culture. (b) Summary of methylation status of the SFRP1 promoter region in 19 MM primary tissue samples. The gene name is indicated on the left, and case numbers are indicated at the top. Each gray (methylation) or open (no methylation) square represents a primary tumor. Genomic DNA was extracted using DNA STAT-60t reagent (TEL-TEST, Inc., Friendswood, TX, USA), according to the manufacture's protocol. Bisulfite modification of genomic DNA was carried out as described previously (Herman et al., 1996) known to be active in this tumor. Abutaily et al. (2003) found that b-catenin accumulates in the nucleus and APC expression is altered in malignant MMs. Similarly, Uematsu et al. (2003) found increased b-catenin levels as well as consistent overexpression of dishevelled (Dvl) in 485% of MMs examined. SFRPs represent a family of secreted proteins that appears primarily to antagonize the Wnt signaling pathway by interfering with Wnt-Fz interaction (Finch et al., 1997; Hu et al., 1998; Bafico et al., 1999) . It has been hypothesized that SFRPs, due to their ability to inhibit Wnt signaling, might function as tumor suppressor genes (Uren et al., 2000; Jones and Jomary, 2002) . Indeed, downregulation of the SFRPs has been found in breast tumors (Zhou et al., 1998; Wong et al., 2002) , cervical cancers (Ko et al, 2002) , and colorectal cancers (Suzuki et al., 2002) . Additionally, SFRP upregulation and overexpression has been associated with increased apoptosis (Zhou et al., 1998; Ko et al, 2002) . The role of sFRP in Wnt signaling and tumorigenesis, however, is still far from clear. Studies have shown that in some circumstances, sFRP may also operate as an agonist to Wnt signaling (Jones and Jomary, 2002) . Although this gene family appears to be significantly downregulated in many cancers, upregulation of SFRP1 and SFRP4 have been found in uterine leiomyomas and endometrial neoplasms, respectively (Abu-Jawdeh et al., 1999; Fukuhara et al., 2002) . Additionally, while previous studies have shown that sFRP overexpression induces apoptosis, Roth et al. (2000) have recently shown that sFRPs promote growth and survival of human malignant glioma cells. The presence of multiple Wnts and Fzs as well as the possible role of sFRP in noncanonical Wnt pathways further complicates the picture. Thus, much work remains to be done in order to gain a clearer understanding of the significance of the sFRPs in Wnt signaling and tumor pathogenesis.
In summary, we demonstrate that the transcription of the SFRP family is frequently downregulated in human MM. We also show that SFRP1, SFRP4, and SFRP5 promoters are frequently methylated in this cancer, and that the restoration of SFRP4 results in growth suppression and apoptosis in cell lines. Together, our data suggests that hypermethylation and downregulation of the SFRPs may be a key feature in human MM. Therefore, SFRPs may serve as promising molecular markers or therapeutic genes for this highly aggressive and inexorably fatal tumor. ) were plated in six-well plates 24 h before transfection. Lipofectamine 2000 (Life Technologies) was used to mediate transfection using 5.0 mg of empty vector or SFRP4 expression vector according to the manufacture's protocol. At 1 week after transfection, the cells were harvested by trypsinization and stained using an Annexin V-FITC Apoptosis Detection Kit (Oncogene Science), according to the manufacturer's protocol. Stained cells were then immediately analyzed by flow cytometry (FACScan, Becton Dickinson) . Early apoptotic cells with exposed phosphatidylserine but intact cell membranes bound to annexin V-FITC but excluded propidium iodide (PI). Cells in necrotic or late apoptotic stages were labeled with both annexin V-FITC and PI. (b) RT-PCR analysis of SFRP4 mRNA levels and Western blot analysis of cytosolic b-catenin and survivin 1 week after the transfection. RNA extraction and RT-PCR were performed as described in Figure 1 . GAPDH was used as an internal control to ensure RNA quality and loading accuracy. Cytosolic proteins were prepared and used in the Western blots. Standard Western blotting protocol was used. b-Actin served as a loading control. Anti-b-catenin, anti-surivin, and anti-b-actin antibodies were purchased from Transduction Laboratories (Lexington, Kentucky), Santa Cruz Biotechnology (Santa Cruz, CA, USA), and Cell Signaling Technology (Beverly, MA, USA), respectively. (c) Colony formation assay using MS-1 and H290 cells. The bar graphs show the average colony numbers in triplicate experiments. Error bars are standard deviations (s.d.) . At 24 h after transfection (as described above), cells were striped and plated on 10 cm cell culture dishes. The cells were then selected by G418 (400 mg/ml). Colonies were stained by using 0.5% methylene blue and counted 3 weeks after the transfection sFRP silencing in human mesothelioma AY Lee et al
